Abstract:Background: Excessive aggregation of P-amyloid peptides (A(3) is regarded as the hallmark of Alzheimer's disease. Exploring the underlying mechanism regulating AP aggregation remains challenging and investigating aggregation events of AP in the presence and absence of metallic ions at molecular level would be meaningful in elucidating the role of metal cations on interactions between AP molecules. In this study, chemical self-assembled monolayer (SAM) method was employed to fabricate monolayer of P-amyloid peptides AP42 on gold substrate with a bolaamphiphile named 16-Mercaptohexadecanoic acid (MHA). Firstly, the samples of gold substrate (blank control), the MHA-modified substrate, and the A(342-modified substrate were detected by X-ray photoelectron spectroscopy (XPS) to track the self-assembly process. Aggregation behaviors of AP42 before and after metallic ions (Zn2+, Ca2+, Al3+) treatment were monitored by atomic force microscopy (AFM) and the interaction between A beta 42 and metallic ions (Zn2+, Ca2+, Al3+) was investigated by surface-enhanced Raman Scattering (SERS). Results: The XPS spectra of binding energy of gold substrate (blank control), the MHA-modified substrate, and the A beta 42-modified substrate are well fitted with the corresponding monolayer's composition, which indicates that A beta 42 monolayer is well formed. The recorded surface morphology of different experimental groups obtained by AFM showed markedly different nanostructures, indicating occurrence of aggregation events between A beta 42 molecules after adding metal ions to the solution. Compared to the control group, the presence of metallic ions resulted in the increased size of surface structures on the observed 3D topography. Besides, the intermolecular rupture force of A beta 42 increased with the addition of metallic ions. Further study by SERS showed that the Raman strength of A beta 42 changes significantly after the metal cation treatment. A considerable part of the amide bonds interacts with metal cations, leading to a structural change, which is characterized by the weakened beta-fold Raman peak. Conclusion: The AFM imaging results suggest that aggregation events occurred between A beta 42 molecules with the addition of metal cations. In addition, the results of force tests indicate that the presence of metallic ions could promote adhesion between A beta 42 molecules, which is likely to be the trigger for aggregation behavior of A beta 42. Furthermore, the effect of metallic cations on the conformational change of A beta 42 studied by SERS supported the results obtained by AFM. Taken together, the results showed that the presence of substoichiometric metal cations promotes aggregation behavior between A beta 42 molecules on the substrate at pH 7.4.

Mercury(Ii) Promotes The In Vitro Aggregation Of Tau Fragment Corresponding To The Second Repeat Of Microtubule-Binding Domain: Coordination And Conformational Transition

The Impacts of Hg(II) Tightly Binding on the Alzheimer’s Tau Construct R3: Misfolding and Aggregation

Cooperative Folding of Tau Peptide by Coordination of Group IIB Metal Cations During Heparin-Induced Aggregation

Impacts of Cd(II) on the Conformation and Self-Aggregation of Alzheimer's Tau Fragment Corresponding to the Third Repeat of Microtubule-Binding Domain

Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR.

Copper (II) Modulates in Vitro Aggregation of a Tau Peptide.

Copper (Cu<SUP>2+</SUP>) ion-induced misfolding of tau protein R3 peptide revealed by enhanced molecular dynamics simulation

Cu2+ Affects Amyloid-\b{eta} (1-42) Aggregation by Increasing Peptide-Peptide Binding Forces

Copper Binding Properties of a Tau Peptide Associated with Alzheimer's Disease Studied by CD, NMR, and MALDI-TOF MS.

Aggregation of Microtubule Binding Repeats of Tau Protein is Promoted by Cu 2 .

Metal ion mediated aggregation of Alzheimer's disease peptides and proteins in solutions and at surfaces

Zinc Binding to Tau Influences Aggregation Kinetics and Oligomer Distribution

Fibrillization Of Human Tau Is Accelerated By Exposure To Lead Via Interaction With His-330 And His-362

Evaluating effect of metallic ions on aggregation behavior of beta-amyloid peptides by atomic force microscope and surface-enhanced Raman Scattering

A new metal ion chelator attenuates human tau accumulation-induced neurodegeneration and memory deficits in mice

Exploring the Interactions of Iron and Zinc with the Microtubule Binding Repeats R1 and R4

Alzheimer disease hyperphosphorylated tau aggregates hydrophobically

Cu(II) potentiation of Alzheimer Abeta1-40 cytotoxicity and transition on its secondary structure

Probing the Role of Metal Cations on the Aggregation Behavior of Amyloid Β-Peptide at a Single Molecule Level by AFM

Pathological Concentration of Zinc Dramatically Accelerates Abnormal Aggregation of Full-Length Human Tau and Thereby Significantly Increases Tau Toxicity in Neuronal Cells.

Evaluating effect of metallic ions on aggregation behavior of β-amyloid peptides by atomic force microscope and surface-enhanced Raman Scattering